XML 130 R110.htm IDEA: XBRL DOCUMENT v3.22.2.2

SEGMENT INFORMATION - Group's reporting segments (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Revenues
Revenue	$ 328,455,588	$ 206,697,620	$ 172,350,699
Royalties	1,995,584	2,023,548	1,775,790
Initial recognition and changes in the fair value of biological assets at the point of harvest	6,388,030	2,826,255	716,741
Changes in the net realizable value of agricultural products after harvest	(42,523)
Government grants		2,302	24,732
Total	334,801,095	209,526,177	173,092,172
Cost of sales	(208,364,095)	(118,641,803)	(93,575,588)
Gross profit.	$ 126,437,000	$ 90,884,374	$ 79,516,584
% Gross margin	38.00%	43.00%	46.00%
Seed and integrated products
Revenues
Revenue	$ 47,858,146	$ 33,422,140	$ 29,402,332
Royalties	1,995,584	2,023,548	1,775,790
Initial recognition and changes in the fair value of biological assets at the point of harvest	3,672,192	1,394,127	41,755
Changes in the net realizable value of agricultural products after harvest	(214,350)
Government grants		2,302	24,732
Total	51,315,988	34,818,569	29,468,819
Cost of sales	(21,839,689)	(12,931,763)	(11,581,494)
Gross profit.	$ 29,476,299	$ 21,886,806	$ 17,887,325
% Gross margin	57.00%	63.00%	61.00%
Crop protection
Revenues
Revenue	$ 173,095,092	$ 113,508,465	$ 93,799,477
Initial recognition and changes in the fair value of biological assets at the point of harvest	1,171,749	606,269	418,712
Changes in the net realizable value of agricultural products after harvest	111,282
Total	174,378,123	114,114,734	94,218,189
Cost of sales	(124,489,307)	(75,138,491)	(53,552,327)
Gross profit.	$ 49,888,816	$ 38,976,243	$ 40,665,862
% Gross margin	29.00%	34.00%	43.00%
Crop nutrition
Revenues
Revenue	$ 107,502,350	$ 59,767,015	$ 49,148,890
Initial recognition and changes in the fair value of biological assets at the point of harvest	1,544,089	825,859	256,274
Changes in the net realizable value of agricultural products after harvest	60,545
Total	109,106,984	60,592,874	49,405,164
Cost of sales	(62,035,099)	(30,571,549)	(28,441,767)
Gross profit.	$ 47,071,885	$ 30,021,325	$ 20,963,397
% Gross margin	43.00%	50.00%	42.00%
Sale of goods and services
Revenues
Revenue	$ 326,460,004	$ 204,674,072	$ 170,574,909
Sale of goods and services | Seed and integrated products
Revenues
Revenue	45,862,562	31,398,592	27,626,542
Sale of goods and services | Crop protection
Revenues
Revenue	173,095,092	113,508,465	93,799,477
Sale of goods and services | Crop nutrition
Revenues
Revenue	$ 107,502,350	$ 59,767,015	$ 49,148,890

X

- Definition

Percentage of gross margin. Gross margin is the amount the entity retains after incurring the direct costs associated with producing the goods it sells and the services it provides.

+ References

No definition available.

+ Details

Name:	biox_GrossMarginPercentage
Namespace Prefix:	biox_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_CostOfSales
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The gains (losses) arising during the current period on the change in fair value less costs to sell of biological assets. [Refer: Biological assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2022-03-24
-Paragraph 40
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_40&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2022-03-24
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2022-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_GrossProfit
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2022-03-24
-Paragraph 28
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2022-03-24
-Paragraph 23
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard
-URIDate 2022-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2022-03-24
-Paragraph 32
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard
-URIDate 2022-03-24

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2022-03-24
-Paragraph 33
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard
-URIDate 2022-03-24

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2022-03-24
-Paragraph 34
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard
-URIDate 2022-03-24

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 5
-IssueDate 2022-03-24
-Paragraph 33
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard
-URIDate 2022-03-24

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B12
-Subparagraph b
-Clause v
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B
-URIDate 2022-03-24

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2022-03-24
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2022-03-24

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 82
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard
-URIDate 2022-03-24

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard
-URIDate 2022-03-24

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 102
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_Revenue
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_RevenueAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2022-03-24
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard
-URIDate 2022-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2022-03-24
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_RevenueFromContractsWithCustomers
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of income recognised in relation to government grants. [Refer: Government grants]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 20
-IssueDate 2022-03-24
-Paragraph 39
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2022-en-r&anchor=para_39_b&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_RevenueFromGovernmentGrants
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of income arising from royalties.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_RevenueFromRoyalties
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	ifrs-full_SegmentsAxis=biox_SeedAndIntegratedProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SegmentsAxis=biox_CropProtectionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_SegmentsAxis=biox_CropNutritionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_ProductsAndServicesAxis=biox_GoodsAndServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: